DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
This bill amends Medicare law to establish a pathway for prompt coverage of FDA-designated breakthrough medical devices. Devices that receive FDA priority review and meet specified clinical criteria would be automatically covered by Medicare for a four-year transitional period following their FDA clearance or approval, unless the Secretary determines they present undue risk. The bill requires the Secretary to make breakthrough device designations within six months of application and to complete national coverage determinations before the transitional period ends, and appropriates $10 million annually through fiscal year 2030 to implement these provisions.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.